Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02222389 · ClinicalTrials.gov registry record · NA
Contingency Management for the Treatment of Co-Occurring Alcohol and Drug Misuse
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT02222389 is a NA study that has completed, run by Washington State University. The registered enrollment target is 120 participants.
The verdict
NCT02222389, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Contingency management (CM) is a type of treatment used in the substance abuse field. Patients' behaviors are rewarded for adherence to a treatment plan. As an approach to treatment, contingency management emerged from the behavior therapy traditions in mental health. By most evaluations, contingency management procedures produce one of the largest effect sizes out of all mental health and educational interventions. The purpose of this study is to perform a randomized, controlled trial to evaluate the ability of a culturally-tailored contingency management (CM) intervention to increase alcohol and drug abstinence among American Indian (AI) tribal members from two rural reservations in the Northwest.
Interventions
- BEHAVIORAL CM for Alcohol
- BEHAVIORAL CM for drugs
- BEHAVIORAL CM for both substances
- BEHAVIORAL Non-Contingent group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2018-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02222389
The ClinicalTrials.gov registry entry for NCT02222389 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which CM for Alcohol is the first listed.
NCT02222389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02222389 about?
NCT02222389 is a clinical study titled "Contingency Management for the Treatment of Co-Occurring Alcohol and Drug Misuse". Contingency management (CM) is a type of treatment used in the substance abuse field. Patients' behaviors are rewarded for adherence to a treatment plan. As an approach to treatment, contingency management emerged from the behavior therapy traditions in mental health. By most evaluations, contingenc...
What is the current status of trial NCT02222389?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-06-01. Estimated completion is 2018-09-10.
What interventions are being tested in trial NCT02222389?
The interventions under investigation include: CM for Alcohol (BEHAVIORAL), CM for drugs (BEHAVIORAL), CM for both substances (BEHAVIORAL), Non-Contingent group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02222389?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.